Worth Venture Partners »

Augmedix shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $80k 14k 5.85
2023-09-30 $83k 16k 5.15

More positions owned by Worth Venture Partners

Bloomin Brands Note 5.000% 5/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Myomo Com New (MYO)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Veradigm Note 0.875% 1/0 (Principal)
Transphorm (TGAN)
Transocean Deb 4.625% 9/3 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Ouster Com New (OUST)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)

View all positions for Worth Venture Partners

Top funds holding Augmedix

Redmile Group
Samjo Management
Divisadero Street Capital Management
Perkins Capital Management
Vanguard Group
Caption Management
Russell Investments
G2 Investment Partners Management
American Financial Group
Balyasny Asset Management
Essex Investment Management
Kennedy Capital Management
Millennium Management
Point72 Asset Management
Resolute Capital Asset Partners

View all funds holding Augmedix